Valeo Pharma Inc. (TSX:VPH, OTCQB:VPHIF) has announced the appointment of Al Moghaddam to its board of directors.
The Kirkland, Quebec-based pharmaceutical company highlighted that Moghaddam brings more than 25 years of global experience as a customer-centric transformational life sciences leader to the board.
He has held leadership positions within the pharmaceutical, medical device, medical technology, and consumer markets., with experience in product life cycle management, sales, business development and licensing, market access, marking, financing, and mergers and acquisitions, it added.
Valeo Pharma chairman Richard MacKay welcomed Moghaddam to the board of directors.
"He is a seasoned and recognized senior pharmaceutical executive with a long track record of superior performance in value creation and industry-leading growth delivery," MacKay said in a statement.
"We look forward to the board benefiting from his valuable insight and perspective."